Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
07/2010
07/07/2010CN101768080A Medicinal compound and medicinal use thereof
07/07/2010CN101768079A Compound and medicinal application thereof
07/07/2010CN101766812A Liquid drug combination containing exenatide or analogues thereof
07/07/2010CN101766811A Application of exenatide acetate or analogue thereof in preparing drug for treating or preventing diabetes complicated with cerebral infarction
07/07/2010CN101766799A Ginseng-monkshood centipede health wine
07/07/2010CN101766794A Traditional Chinese medicine formula for treating diabetes mellitus and oral liquid preparation method thereof
07/07/2010CN101766776A Traditional Chinese medicine formula for treating diabetes mellitus and preparation method thereof
07/07/2010CN101766769A Traditional Chinese medicine granular formulation for treating diabetes mellitus
07/07/2010CN101766760A Traditional Chinese medicine oral liquid for treating diabetes mellitus
07/07/2010CN101766755A Traditional Chinese pill for reducing blood glucose and preparation method thereof
07/07/2010CN101766753A Vitality source capsule and preparation method thereof
07/07/2010CN101766752A Traditional Chinese medicine combination for treating diabetes mellitus and preparation method thereof
07/07/2010CN101766738A Traditional Chinese medicine pill for treating II type diabetes mellitus
07/07/2010CN101766706A Medicinal combination containing borneol and musk
07/07/2010CN101766705A Medicinal combination containing borneol and musk
07/07/2010CN101766704A Medicinal combination containing borneol and musk
07/07/2010CN101766703A Medicinal combination containing borneol and musk
07/07/2010CN101766702A Medicinal combination containing borneol and musk
07/07/2010CN101766701A Medicinal combination containing musk
07/07/2010CN101766700A Medicinal combination containing musk
07/07/2010CN101766699A Medicinal combination containing musk
07/07/2010CN101766678A Application of total flavonoid in astragalus to preparing medicaments for preventing and controlling diabetes and nephropathy
07/07/2010CN101766675A Preparation method of silktree albizia bark extract for inhibiting angiogenesis and application
07/07/2010CN101766668A Burdock extract and preparation method and application thereof
07/07/2010CN101766666A Chinese medicament for treating cardiovascular and cerebrovascular diseases
07/07/2010CN101766657A Compound for activating immune cell and preparation method thereof
07/07/2010CN101766652A Propolis donkey-hide geltin
07/07/2010CN101766618A New use of pitavastatin calcium and drug aiming at new use
07/07/2010CN101766594A Officinal composition for lowering blood fat
07/07/2010CN101766593A Medical composition containing amorphous atorvastatin calcium
07/07/2010CN101766592A Sustained-release preparation capable of lowering blood fat
07/07/2010CN101766578A Tablet containing Rosuvastatin calcium and preparation process thereof
07/07/2010CN101766574A Preparation formulations of sodium pyruvate freeze-dried powder injection, injection and solid agent and production processes thereof
07/07/2010CN101766563A Combination use method of water-soluble vitamin injection and sodium chloride injection
07/07/2010CN101766297A Flour for diabetes food therapy
07/07/2010CN101766296A Functional food for weight loosing and preparation process thereof
07/07/2010CN101766258A Traditional Chinese medicinal composition and application thereof as pig feed additive
07/07/2010CN101766245A Preparation method of health food silkworm tea mixture capable of lowering blood sugar
07/07/2010CN101766228A Iimmune stimulatory infant nutrition
07/07/2010CN101225361B Golden fungus fermentation liquor or sesquiterpenes produced by fermentation of golden fungus liquid
07/07/2010CN101167743B Compound xylitol electrolyte injection and preparation method thereof
07/07/2010CN101032532B Medicine composition including active substrates extracted from Sang Huang, the preparing method and the application in the producing of medicine thereof
07/06/2010US7750150 Process for producing acid adduct salt of polyacidic base compound
07/06/2010US7750015 Nitrogen-containing heterocyclic compounds and methods of use thereof
07/06/2010US7750000 Substituted imidazo[1,2b]pyridazines as kinase inhibitors, their preparation and use as medicaments
07/06/2010US7749992 modulators of Cholesterol ester transfer protein activity, such as 5-[Acetyl-(3,5-bis-trifluoromethyl-benzyl)-amino]-7-trifluoromethyl-2,3,4,5-tetrahydro-benzo[b]azepine-1-carboxylic acid isopropyl ester, for treating or preventing cardiovascular disorders
07/06/2010US7749986 Homogeneously formulating microdosed active principles
07/06/2010US7749971 Such as Hurler syndrome and Batten by administering an aminoglycosidesuch as gentamicin, G418, hygromycin B, paromomycin, tobramycin, lividomycin A, amikacin, sisomycin, or neomycin, optionally in combination with an enzyme effective for enzyme replacement therapy, a polyionic compound or gene therapy
07/06/2010US7749960 An enteral composition or a pharmaceutical containing osteoprotegerin obtained from human or bovine milk or colostrum; preventing or treating disorders associated with bone metabolism and immune function
07/06/2010US7749752 Using vector comprisng nucleotide sequences coding cell binding elements to transform cells and identify lymphocyte response modulators
07/06/2010US7749735 Interferon receptor variant for treatment and prevention of cell proliferative, autoimmune and viral diseases; prolonged activation of interferon beta
07/06/2010US7749718 Method for raising or isolating an antibody to DCRS5
07/06/2010US7749543 Methods useful in the treatment of bone resorption diseases
07/06/2010US7749513 lowering plasma cholesterol level in a subject by administering a preparation comprising an isolated membrane fraction separated from cytoplasmic material, the membrane fraction made from bacteria of Rhodospirillum spp. and/or Phaeospirillum spp
07/06/2010US7749495 Method for inducing an anti-tumor and anti-cachexia immune response in mammals
07/06/2010CA2454863C Novel pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine
07/06/2010CA2446149C Vitamin d analogues
07/06/2010CA2415962C Valsartan salts
07/06/2010CA2359462C Pyrazole compounds and uses thereof
07/06/2010CA2298864C Chemical modification of proteins to improve biocompatibility and bioactivity
07/06/2010CA2177858C Benzimidazole derivatives, their preparation and their therapeutic use
07/01/2010WO2010075469A1 Corydaline derivatives useful for reducing lipid levels
07/01/2010WO2010075273A1 Bicyclic heterocycle derivatives and methods of use thereof
07/01/2010WO2010075271A1 Bicyclic heterocycle derivatives and methods of use thereof
07/01/2010WO2010075269A1 Pyrimidine derivatives as gpcr modttlators for use in the treatment of obesity and diabetes
07/01/2010WO2010075069A1 Bicyclic pyranone derivatives as nicotinic acid receptor agonists
07/01/2010WO2010075010A2 Oligosaccharide-protein conjugates
07/01/2010WO2010074807A1 3, 4-dihydroquinolin-2 ( 1h ) -one derivatives as sodium channel modulators
07/01/2010WO2010074271A1 Therapeutic agent for diabetes
07/01/2010WO2010074220A1 Composition containing sesamins and epigallocatechin gallate
07/01/2010WO2010074219A1 Benzothiophen compound
07/01/2010WO2010074089A1 Indanyl compounds
07/01/2010WO2010074088A1 Cyclic amine compounds
07/01/2010WO2010073642A1 Bioactive agent, pharmaceutical product, cosmetic product, freshness keeping agent, and plant and animal growth promoting agent
07/01/2010WO2010073235A1 Ppar agonist compositions and methods of use
07/01/2010WO2010073173A1 Maintenance fluid for animals
07/01/2010WO2010073011A2 Compounds useful as medicaments
07/01/2010WO2010072950A1 Formulation for delivering lipid-lowering drugs by oral transmucosal administration
07/01/2010WO2010072607A1 Dihydropyridone amides as p2x7 modulators
07/01/2010WO2010046445A3 Urea derivatives of substituted nortropanes, medicaments containing such compounds and their use
07/01/2010WO2010045258A3 Spirocyclic gpr40 modulators
07/01/2010WO2010039461A3 Methods for synthesis and uses of inhibitors of ghrelin o-acyltransferase as potential therapeutic agents for obesity and diabetes
07/01/2010WO2010033981A3 5-azaindole bisphosphonates
07/01/2010WO2010028842A3 Phenyl malonic acid derivatives
07/01/2010WO2010025410A3 Screening method for identifying patients at risk of adverse hepatologic events
07/01/2010US20100168244 Naphthalene compounds, a process for their preparation and pharmaceutical compositions containing them
07/01/2010US20100168224 Hypoglycemic Activity of Osthole
07/01/2010US20100168218 Method of reducing food intake
07/01/2010US20100168210 T-Cell Cytokine-Inducing Surface Molecules and Methods of Use
07/01/2010US20100168199 Kinase Inhibitors
07/01/2010US20100168195 Derivatives and analogs of chroman as functionally selective alpha2c adrenoreceptor agonists
07/01/2010US20100168192 Benzisoxazole derivatives as potassium channel modulators for the treatment of e.g. respiratory diseases, epilepsy and convulsions
07/01/2010US20100168188 Estrogen Receptor Modulators
07/01/2010US20100168187 Therapeutic combination
07/01/2010US20100168183 Subsituted cyclic compound, its preparation process and its medical use
07/01/2010US20100168169 Substituted 1,3-dioxanes useful as ppar modulators
07/01/2010US20100168168 Aminoaryl sulphonamide derivatives as functional 5-HT6 ligands
07/01/2010US20100168164 Antidiabetic Oxazolidinediones and Thiazolidinediones
07/01/2010US20100168158 Modulators of cystic fibrosis transmembrane conductance regulator
07/01/2010US20100168156 Novel Benzoxathiine Derivative
1 ... 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 ... 1298